GE Healthcare SenoClaire 3D Breast Tomosynthesis - Manual (Page 2)

> See more clearly
SenoClaire improves the specificity of mammography by improving
lesion margin visibility.
> Screen more effectively
Due to its low dose and non-inferior clinical accuracy, SenoClaire has the potential
to replace digital mammography exams in screening at half the dose to detect
breast cancer. As part of the learning curve process, an additional CC view may be
considered along with the 3D MLO view, which will help radiologists become more
comfortable with reviewing only the 3D MLO sequence in the near future.
> Characterize more specifically
SenoClaire enables better characterization of malignant and benign findings
by providing a 3D MLO view that has superior detection for architectural distortions
and masses
1 compared with 2D FFDM. Clinical results have shown that the recall
rate after a 3D MLO examination is lower than the recall rate after a 2D FFDM exam.
Powered by SenoClaire technology:
• The SenoClaire detector delivers high DQE at low dose for visualizing
microcalcifications without binning, a process that regroups pixels for faster
readout speeds and improved signal-to-noise ratios, but with reduced image quality.
• Step-and-shoot tube motion preserves microcalcification sharpness and avoids
image blur, since the tube makes a complete stop for each of the nine exposures.
This provides higher peak contrast for microcalcifications than traditional
continuous tube motion.
• An anti-scatter solution designed for tomosynthesis, the SenoClaire grid in 3D
reduces scattered radiation and improves detectability in 3D for breasts of
above-average thickness, while preserving dose and performance.
• SenoClaire uses ASiR DBT , an iterative reconstruction algorithm that yields FFDM-like
images and positively impacts microcalcification conspicuity versus the traditional
Filtered Back Projection (FBP) algorithm.
Care with confidence
Because GE builds the Senographe with upgradability
in mind, you can easily expand the system as your
needs and capabilities grow. SenoClaire 3D breast
tomosynthesis, stereotaxy, or SenoBright
* contrast
enhanced spectral mammography are fully
compatible with any Senographe Essential and
Senographe Care. It’s an excellent balance of precision
and performance, so you can be confident in your
investment.
Connect with compatibility
SenoClaire images are compatible with major PACS
providers (with local variability), allowing integration
into your environment and helping you make
optimal use of your investment. With the IDI
MammoWorkstation, radiologists can smoothly
navigate through the DBT dataset using dedicated
2D/3D hanging protocols and specific ergonomic
features:
• Straightforward visual identification of all series
of tomosynthesis planes and slabs
• Dedicated tools to review tomosynthesis data sets:
cine loop, bookmarks, breast localizer,
breast height ruler
• V-Preview reconstructed images from tomosynthesis
1GE190-004 BIE (Blinded Imaging Evaluation) study – US. A Multicenter Study to Test the Non-Inferiority of Digital Breast Tomosynthesis
Compared to FFDM in Detecting Breast Cancer
M O R E C L A R I T Y M O R E CO N F I D EN C E
2D MLO
3D MLO V-preview